NVS logo

Novartis AG (NVS) Free cash flow

annual FCF:

$13.80B+$2.09B(+17.87%)
December 31, 2024

Summary

  • As of today (August 18, 2025), NVS annual free cash flow is $13.80 billion, with the most recent change of +$2.09 billion (+17.87%) on December 31, 2024.
  • During the last 3 years, NVS annual FCF has risen by +$1.76 billion (+14.60%).
  • NVS annual FCF is now at all-time high.

Performance

NVS Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

quarterly FCF:

$6.19B+$4.04B(+187.79%)
June 30, 2025

Summary

  • As of today (August 18, 2025), NVS quarterly free cash flow is $6.19 billion, with the most recent change of +$4.04 billion (+187.79%) on June 30, 2025.
  • Over the past year, NVS quarterly FCF has increased by +$2.04 billion (+49.28%).
  • NVS quarterly FCF is now -35.20% below its all-time high of $9.55 billion, reached on September 30, 2007.

Performance

NVS quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

TTM FCF:

$16.89B+$2.04B(+13.76%)
June 30, 2025

Summary

  • As of today (August 18, 2025), NVS TTM free cash flow is $16.89 billion, with the most recent change of +$2.04 billion (+13.76%) on June 30, 2025.
  • Over the past year, NVS TTM FCF has increased by +$5.18 billion (+44.18%).
  • NVS TTM FCF is now at all-time high.

Performance

NVS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

NVS Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.9%+49.3%+44.2%
3 y3 years+14.6%+95.2%+50.3%
5 y5 years+22.0%+76.8%+36.5%

NVS Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+17.9%at high+458.2%at high+64.9%
5 y5-yearat high+25.4%at high+683.6%at high+64.9%
alltimeall timeat high+1592.4%-35.2%+784.9%at high+1690.9%

NVS Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$6.19B(+187.8%)
$16.89B(+13.8%)
Mar 2025
-
$2.15B(-29.8%)
$14.85B(+7.5%)
Dec 2024
$13.80B(+17.9%)
$3.06B(-44.2%)
$13.80B(+10.4%)
Sep 2024
-
$5.49B(+32.3%)
$12.51B(+6.8%)
Jun 2024
-
$4.15B(+273.9%)
$11.71B(+14.3%)
Mar 2024
-
$1.11B(-37.1%)
$10.25B(-12.5%)
Dec 2023
$11.71B(-2.4%)
$1.76B(-62.4%)
$11.71B(-13.6%)
Sep 2023
-
$4.70B(+75.4%)
$13.56B(+2.1%)
Jun 2023
-
$2.68B(+4.0%)
$13.29B(-3.6%)
Mar 2023
-
$2.57B(-28.8%)
$13.78B(+14.9%)
Dec 2022
$12.00B(-0.4%)
$3.61B(-18.3%)
$12.00B(+6.3%)
Sep 2022
-
$4.42B(+39.4%)
$11.29B(+0.4%)
Jun 2022
-
$3.17B(+301.5%)
$11.24B(-2.9%)
Mar 2022
-
$790.00M(-72.8%)
$11.57B(-3.9%)
Dec 2021
$12.04B(+9.4%)
$2.90B(-33.6%)
$12.04B(-0.6%)
Sep 2021
-
$4.37B(+24.7%)
$12.11B(+18.0%)
Jun 2021
-
$3.50B(+178.2%)
$10.26B(+0.0%)
Mar 2021
-
$1.26B(-57.6%)
$10.26B(-6.8%)
Dec 2020
$11.00B(-2.7%)
$2.98B(+17.9%)
$11.00B(+0.9%)
Sep 2020
-
$2.52B(-28.0%)
$10.91B(-11.9%)
Jun 2020
-
$3.50B(+74.8%)
$12.37B(+7.3%)
Mar 2020
-
$2.00B(-30.4%)
$11.53B(+2.0%)
Dec 2019
$11.31B(-2.4%)
$2.88B(-27.9%)
$11.31B(-2.0%)
Sep 2019
-
$3.99B(+50.2%)
$11.53B(+7.4%)
Jun 2019
-
$2.66B(+49.0%)
$10.74B(-6.9%)
Mar 2019
-
$1.78B(-42.5%)
$11.53B(-0.5%)
Dec 2018
$11.59B(+17.0%)
$3.10B(-2.9%)
$11.59B(+5.8%)
Sep 2018
-
$3.20B(-7.4%)
$10.95B(+0.5%)
Jun 2018
-
$3.45B(+87.9%)
$10.89B(+4.4%)
Mar 2018
-
$1.84B(-25.6%)
$10.43B(+5.3%)
Dec 2017
$9.90B(+15.2%)
$2.47B(-21.4%)
$9.90B(-5.8%)
Sep 2017
-
$3.14B(+5.0%)
$10.51B(+15.8%)
Jun 2017
-
$2.99B(+127.7%)
$9.08B(+3.7%)
Mar 2017
-
$1.31B(-57.3%)
$8.75B(+1.8%)
Dec 2016
$8.60B(+2.4%)
$3.08B(+80.8%)
$8.60B(+10.4%)
Sep 2016
-
$1.70B(-36.1%)
$7.79B(-9.8%)
Jun 2016
-
$2.66B(+130.2%)
$8.63B(+3.8%)
Mar 2016
-
$1.16B(-48.9%)
$8.31B(-0.9%)
Dec 2015
$8.39B(-20.0%)
$2.27B(-11.0%)
$8.39B(-13.7%)
Sep 2015
-
$2.55B(+8.7%)
$9.72B(-10.9%)
Jun 2015
-
$2.34B(+89.8%)
$10.91B(-1.1%)
Mar 2015
-
$1.24B(-65.6%)
$11.03B(+5.1%)
Dec 2014
$10.49B(+7.1%)
$3.60B(-3.7%)
$10.49B(+6.8%)
Sep 2014
-
$3.73B(+51.6%)
$9.82B(-2.1%)
Jun 2014
-
$2.46B(+252.2%)
$10.04B(+9.6%)
Mar 2014
-
$699.56M(-76.1%)
$9.16B(-6.5%)
Dec 2013
$9.80B
$2.93B(-25.8%)
$9.80B(-7.8%)
Sep 2013
-
$3.95B(+149.1%)
$10.62B(+5.8%)
DateAnnualQuarterlyTTM
Jun 2013
-
$1.58B(+18.4%)
$10.04B(-4.1%)
Mar 2013
-
$1.34B(-64.4%)
$10.47B(-5.9%)
Dec 2012
$11.13B(-5.7%)
$3.75B(+11.6%)
$11.13B(-1.2%)
Sep 2012
-
$3.37B(+67.2%)
$11.26B(-1.6%)
Jun 2012
-
$2.01B(+0.9%)
$11.43B(-7.1%)
Mar 2012
-
$1.99B(-48.7%)
$12.31B(+4.3%)
Dec 2011
$11.80B(+0.5%)
$3.88B(+9.7%)
$11.80B(+0.3%)
Sep 2011
-
$3.54B(+22.8%)
$11.76B(+6.3%)
Jun 2011
-
$2.88B(+94.0%)
$11.06B(+6.7%)
Mar 2011
-
$1.49B(-61.4%)
$10.37B(-11.7%)
Dec 2010
$11.74B(+24.6%)
$3.85B(+35.4%)
$11.74B(+3.2%)
Sep 2010
-
$2.84B(+29.6%)
$11.37B(+2.2%)
Jun 2010
-
$2.19B(-23.3%)
$11.13B(+0.6%)
Mar 2010
-
$2.86B(-17.8%)
$11.06B(+13.0%)
Dec 2009
$9.42B(+26.4%)
$3.48B(+34.1%)
$9.79B(+9.9%)
Sep 2009
-
$2.59B(+21.7%)
$8.91B(+0.8%)
Jun 2009
-
$2.13B(+34.5%)
$8.84B(+10.5%)
Mar 2009
-
$1.59B(-39.0%)
$8.00B(+4.4%)
Dec 2008
$7.45B(+22.6%)
$2.60B(+3.0%)
$7.66B(+51.3%)
Sep 2008
-
$2.52B(+95.4%)
$5.06B(-58.1%)
Jun 2008
-
$1.29B(+3.4%)
$12.09B(+0.8%)
Mar 2008
-
$1.25B(-86.9%)
$11.99B(-3.5%)
Dec 2007
$6.08B(+0.0%)
-
-
Sep 2007
-
$9.55B(+701.7%)
$12.43B(+186.0%)
Jun 2007
-
$1.19B(-29.3%)
$4.35B(-1.6%)
Mar 2007
-
$1.69B(+14.8%)
$4.42B(-33.5%)
Dec 2006
$6.07B(-6.0%)
-
-
Sep 2006
-
$1.47B(+16.5%)
$6.64B(-10.2%)
Jun 2006
-
$1.26B(-38.5%)
$7.39B(-6.3%)
Mar 2006
-
$2.05B(+10.5%)
$7.89B(+13.9%)
Dec 2005
$6.46B(+26.3%)
$1.86B(-16.5%)
$6.92B(+8.8%)
Sep 2005
-
$2.22B(+26.3%)
$6.37B(+7.9%)
Jun 2005
-
$1.76B(+62.2%)
$5.90B(+8.5%)
Mar 2005
-
$1.09B(-16.4%)
$5.44B(+2.7%)
Dec 2004
$5.12B(+0.9%)
$1.30B(-26.0%)
$5.30B(+32.5%)
Sep 2004
-
$1.75B(+35.0%)
$4.00B(+78.2%)
Jun 2004
-
$1.30B(+37.8%)
$2.24B(+137.8%)
Mar 2004
-
$943.12M(-60.1%)
$943.12M(-60.1%)
Dec 2003
$5.07B(+24.0%)
-
-
Dec 2002
$4.09B(-542.3%)
$2.36B
$2.36B
Dec 2001
-$924.52M(-150.2%)
-
-
Dec 2000
$1.84B(-43.4%)
-
-
Dec 1999
$3.25B(+19.2%)
-
-
Dec 1998
$2.73B(+132.6%)
-
-
Dec 1997
$1.17B(-49.1%)
-
-
Dec 1996
$2.30B(-17.3%)
-
-
Dec 1995
$2.79B(+90.1%)
-
-
Dec 1994
$1.47B(+7.7%)
-
-
Dec 1993
$1.36B
-
-

FAQ

  • What is Novartis AG annual free cash flow?
  • What is the all time high annual FCF for Novartis AG?
  • What is Novartis AG annual FCF year-on-year change?
  • What is Novartis AG quarterly free cash flow?
  • What is the all time high quarterly FCF for Novartis AG?
  • What is Novartis AG quarterly FCF year-on-year change?
  • What is Novartis AG TTM free cash flow?
  • What is the all time high TTM FCF for Novartis AG?
  • What is Novartis AG TTM FCF year-on-year change?

What is Novartis AG annual free cash flow?

The current annual FCF of NVS is $13.80B

What is the all time high annual FCF for Novartis AG?

Novartis AG all-time high annual free cash flow is $13.80B

What is Novartis AG annual FCF year-on-year change?

Over the past year, NVS annual free cash flow has changed by +$2.09B (+17.87%)

What is Novartis AG quarterly free cash flow?

The current quarterly FCF of NVS is $6.19B

What is the all time high quarterly FCF for Novartis AG?

Novartis AG all-time high quarterly free cash flow is $9.55B

What is Novartis AG quarterly FCF year-on-year change?

Over the past year, NVS quarterly free cash flow has changed by +$2.04B (+49.28%)

What is Novartis AG TTM free cash flow?

The current TTM FCF of NVS is $16.89B

What is the all time high TTM FCF for Novartis AG?

Novartis AG all-time high TTM free cash flow is $16.89B

What is Novartis AG TTM FCF year-on-year change?

Over the past year, NVS TTM free cash flow has changed by +$5.18B (+44.18%)
On this page